Michael Friedman, MD
Otolaryngology · Chicago, ILNPI 1932161056
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,160 of the $5,997 with a category attached, or 69.4%. Cook Incorporated accounts for 69.4% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $4,689 and has fallen 97.1% since, to $138 in 2025.
Across 56 payments — averaging $107.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$4K
- Inspire Medical Systems, Inc.$719
- Acclarent, Inc$251
- Neurent Medical Limited$249
- GSK$182
- Smith+Nephew$51
- plus $384 from 16 others
Across 15 payments — averaging $4125.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aerin Medical Inc.$46K
- Biohaven Pharmaceutical Holding Company Ltd.$14K
- Livanova USA, Inc.$1K
What the payments were for
- Consulting fees$4,16069%
- Speaking & faculty fees$2504%
- Food & beverage$1,58726%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 1 | $4,160 |
| Inspire Medical Systems, Inc. | 9 | $719 |
| Acclarent, Inc | 8 | $251 |
| Neurent Medical Limited | 8 | $249 |
| GSK | 9 | $182 |
| Smith+Nephew | 2 | $51 |
| Stryker | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| Philips North America LLC | 2 | $32 |
| Merck | 1 | $24 |
| Fisher & Paykel Healthcare Inc | 1 | $24 |
| Medtronic | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Cook Medical LLC | 1 | $23 |
| Hospira, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $17 |
| Harmony Biosciences LLC | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
| Lucid Diagnostics Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,997 in reported general payments places this provider in the 85th percentile of 390 otolaryngology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RyaltrisOlopatadine Hcl/Mometasone | 14 | $3,334 |
| Azelastine Hcl | 74 | $2,265 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 21 | $2,205 |
| Fluticasone Propionate | 135 | $1,629 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 109 | $1,177 |
| Cevimeline Hcl | 21 | $1,175 |
| Omeprazole | 76 | $1,138 |
| Ipratropium Bromide | 55 | $975 |
| Pantoprazole Sodium | 108 | $861 |
| Methylprednisolone | 67 | $427 |
| Levothyroxine Sodium | 34 | $405 |
| Montelukast Sodium | 27 | $373 |
| Amoxicillin | 97 | $367 |
| Doxepin Hcl | 21 | $273 |
| Prednisone | 16 | $242 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USARyaltris | $20 | $3,33414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 390 otolaryngology providers in Illinois.
Other otolaryngology in Chicago
- David ConleyChicago$630K
- Jayant PintoChicago$628K
- Robert KernChicago$610K
- Victoria LeeChicago$86K
- Louis PortugalChicago$68K
- Dean ToriumiChicago$63K
- Monica PatadiaChicago$56K
- Phillip LosavioChicago$53K
- Fuad BaroodyChicago$46K
- Bruce TanChicago$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.